The med-tec company PolarCool AB (publ) continues to establish the PolarCap System in Finnish hockey. The company has now entered into a 2-year agreement with the professional club Rauman Lukko for the use of two PolarCap Systems.

PolarCool develops and markets the product PolarCap System which alleviates the effects of concussion. The primary users of PolarCap System include sports clubs, organizations, and facilities in contact sports such as ice hockey, rugby, and handball, but also other sports with an increased risk of concussion.

Earlier this autumn, PolarCool signed its first agreement in the Liiga, by bringing onboard KalPa. Both agreements are limited in size but are an important strategic step for PolarCool, as part of the companies aim to obtain a league-wide solution with the Liiga.

Rauman Lukko play in the top league of Finnish hockey, the Liiga, and the agreement with the club is a significant step towards PolarCool’s further establishment in the Finnish market. The agreement includes two PolarCap Systems, to ensure that the club have treatment at both home and away games.

Rauman Lukko's team doctor, Dr. Harri Hakkarainen comments:

-We look forward to being able to include the PolarCap System in our routines for concussions in all our elite teams, both at home and away games. We prioritize giving our players the best possible conditions to alleviate the effects of concussions.

PolarCool's CEO, Erik Andersson comments:

-In line with our ambition to continue establishing ourselves on the Finnish market, the agreement with Rauman Lukko is a success. The fact that the club also wants a solution with two PolarCap Systems to secure use for home- and away game treatment for its players is a solution we hope more clubs will follow. Our goal in the long term is that the PolarCap System will be available in all arenas.

Away from Finnish hockey, PolarCool has also established a strong position within Swedish hockey and since 2019 has held a league agreement with the Swedish Hockey League, SHL. Recently, the company has also entered into several agreements with other European hockey clubs.

 For more information

Erik Andersson –  CEO PolarCool AB (publ)               
+46 - 738 60 57 00                                         
E-mail: erik.andersson@polarcool.se 

About PolarCool AB (publ)

PolarCool AB (publ) is a medical device company that develops, markets, and sells products for sports medicine. The company focuses on treatment of concussive and sub-concussive brain injury with the portable cooling device PolarCap® System. PolarCool AB (publ) is based in Lund, Sweden, and its shares are listed on Spotlight Stock Market.